Arkolith/Insider Trading/RNA/Form 4

Flanagan W. Michael

Chief Scientific OfficerAvidity Biosciences, Inc. (RNA) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$473K
Net Open-Market Flow
-$473K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)3K$72.45$185K85K
Jan 21, 2026Sell(S)4K$72.45$288K88K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599901-26-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML